Myelodysplastic Syndromes
A brief digest about this topic
Your bone marrow is the spongy tissue inside some of your bones, such as your hip and thigh bones. It contains immature cells, called stem cells. The stem cells can develop into the red blood cells that carry oxygen through your body, the white blood cells that fight infections, and the platelets that help with blood clotting. If you have a myelodysplastic syndrome, the stem cells do not mature into healthy blood cells. This leaves less room for healthy cells, which can lead to infection, anemia, or easy bleeding.
Myelodysplastic syndromes often do not cause early symptoms and are sometimes found during a routine blood test. If you have symptoms, they may include
- Shortness of breath
- Weakness or feeling tired
- Skin that is paler than usual
- Easy bruising or bleeding
- Pinpoint spots under the skin caused by bleeding
- Fever or frequent infections
Myelodysplastic syndromes are rare. People at higher risk are over 60, have had chemotherapy or radiation therapy, or have been exposed to certain chemicals. Treatment options include transfusions, drug therapy, chemotherapy, and blood or bone marrow stem cell transplants.
NIH National Cancer Institute
Provided by: NIH - National Institute of Health
Links shared publicly online about this topic
Myelodysplastic Syndromes on #MDlinx
mdlinx.com — “Myelodysplastic Syndromes on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on October 13, 2010 at 11:54 pm By:
Practical use of azacitidine in higher-risk myelodysplastic syndromes: An expert panel opinion: Leukemia ... http://bit.ly/cpE8Ez #medicine
Oncology Article | Myelodysplastic Syndromes
mdlinx.com — “Evaluation of comorbidities at diagnosis predicts outcome in myelodysplastic syndrome patients” View full resource at mdlinx.com
Most Recently Shared on February 15, 2011 at 10:35 am By:
Evaluation of comorbidities at diagnosis predicts outcome in myelodysplastic syndrome patients: Leukem... http://bit.ly/gQlPF0 #oncology
Oncology Article | Myelodysplastic Syndromes
mdlinx.com — “Japanese phase I/II study of azacitidine in patients with myelodysplastic syndromes” View full resource at mdlinx.com
Most Recently Shared on June 1, 2011 at 10:57 am By:
Japanese phase I/II study of azacitidine in patients with myelodysplastic syndromes: Cancer Science http://bit.ly/khAzQX #oncology
Oncology Article | Myelodysplastic Syndromes
mdlinx.com — “Myelodysplastic syndromes: 2011 update on diagnosis, risk-stratification, and management” View full resource at mdlinx.com
Most Recently Shared on June 6, 2011 at 3:29 pm By:
Myelodysplastic syndromes: 2011 update on diagnosis, risk-stratification, and management: American Jou... http://bit.ly/kJe0JA #oncology
Oncology Article | Myelodysplastic Syndrome
mdlinx.com — “Outcome of High-Risk Myelodysplastic Syndrome After Azacitidine Treatment Failure” View full resource at mdlinx.com
Most Recently Shared on July 28, 2011 at 12:03 pm By:
Outcome of High-Risk Myelodysplastic Syndrome After Azacitidine Treatment Failure: Journal of Clinical... http://bit.ly/pdnSl7 #oncology
Myelodysplastic Syndrome (MDS)
fhcrc.org — “Hutchinson Center research related to Myelodysplastic Syndrome (MDS), Myelodysplasia information and risk of Myelodysplastic Syndrome. Hutchinson Center, Seattle, WA” View full resource at fhcrc.org
Most Recently Shared on July 27, 2010 at 4:19 pm By:
New videos: Watch our experts share info for patients & families battling myelodysplastic syndrome & related diseases http://ow.ly/2hgJY
Oncology Article | myelodysplastic syndromes
mdlinx.com — “Cardiac iron overload in transfusion-dependent patients with myelodysplastic syndromes” View full resource at mdlinx.com
Most Recently Shared on June 29, 2011 at 2:59 pm By:
Cardiac iron overload in transfusion-dependent patients with myelodysplastic syndromes: British Journa... http://bit.ly/k4nLMF #oncology
Oncology Article | Myelodysplastic Syndromes
mdlinx.com — “Coalesced multicentric analysis of 2,351 patients with myelodysplastic syndromes indicates an underestimation of poor-risk cytogenetics of myelodysplastic syndromes in the international prognostic scoring system” View full resource at mdlinx.com
Most Recently Shared on April 28, 2011 at 7:10 am By:
Coalesced multicentric analysis of 2,351 patients with myelodysplastic syndromes indicates an underest... http://bit.ly/jMWRHt #oncology
Oncology Article | myelodysplastic syndrome
mdlinx.com — “Reduced ribosomal protein gene dosage and p53 activation in low risk myelodysplastic syndrome” View full resource at mdlinx.com
Most Recently Shared on July 27, 2011 at 5:32 pm By:
Reduced ribosomal protein gene dosage and p53 activation in low risk myelodysplastic syndrome: Blood http://bit.ly/qsXZrx #oncology
Oncology Article - Myelodysplastic Syndromes
mdlinx.com — “Prognostic factors of response and overall survival in 282 higher-risk myelodysplastic syndromes treated with azacitidine” View full resource at mdlinx.com
Most Recently Shared on October 28, 2010 at 9:49 am By:
Prognostic factors of response and overall survival in 282 higher-risk myelodysplastic syndromes treated ... http://bit.ly/d7hh2e #oncology
Oncology Article | Myelodysplastic Syndromes
mdlinx.com — “Outcomes after induction chemotherapy in patients with acute myeloid leukemia arising from myelodysplastic syndrome” View full resource at mdlinx.com
Most Recently Shared on November 30, 2010 at 1:12 am By:
Outcomes after induction chemotherapy in patients with acute myeloid leukemia arising from myelodyspla... http://bit.ly/exZTcL #oncology
Oncology Article | Myelodysplastic syndrome
mdlinx.com — “Increased serum hepcidin levels during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndrome” View full resource at mdlinx.com
Most Recently Shared on March 10, 2011 at 6:41 pm By:
Increased serum hepcidin levels during treatment with deferasirox in iron-overloaded patients with mye... http://bit.ly/hfAy4k #oncology
Oncology Article | myelodysplastic syndrome
mdlinx.com — “A randomized study of 2 dose levels of intravenous clofarabine in the treatment of patients with higher-risk myelodysplastic syndrome” View full resource at mdlinx.com
Most Recently Shared on July 20, 2011 at 1:27 pm By:
A randomized study of 2 dose levels of intravenous clofarabine in the treatment of patients with highe... http://bit.ly/qCtWjE #oncology
Oncology Article | Myelodysplastic Syndromes
mdlinx.com — “Safety, pharmacokinetics, and immunomodulatory effects of lenalidomide in children and adolescents with relapsed/refractory solid tumors or myelodysplastic syndrome: A childrens oncology group phase I consortium report” View full resource at mdlinx.com
Most Recently Shared on December 16, 2010 at 5:29 am By:
Safety, pharmacokinetics, and immunomodulatory effects of lenalidomide in children and adolescents wit... http://bit.ly/ePhp3z #oncology
Oncology Article | Myelodysplastic Syndromes
mdlinx.com — “Alemtuzumab Treatment of Intermediate-1 Myelodysplasia Patients Is Associated With Sustained Improvement in Blood Counts and Cytogenetic Remissions” View full resource at mdlinx.com
Most Recently Shared on November 22, 2010 at 3:11 pm By:
Alemtuzumab Treatment of Intermediate-1 Myelodysplasia Patients Is Associated With Sustained Improveme... http://bit.ly/cTZaXW #oncology
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement

